Introduction. Medication adherence is a public health problem and this has not been previously studied in myasthenia gravis patients Aim. To determine if patients with myasthenia gravis are adherent to treatment and ...

Myasthenia gravis has traditionally been viewed as a disorder that solely affects the neuromuscular junction within the peripheral nervous system. However, there is now evidence that the cholinergic dysfunction of this ...

An unusual association of asthma and myasthenia gravis (MG) complicated by tracheal stenosis is reported. The patient was a 35-year-old black woman with a history of severe asthma and rhinitis over 30 years. A respiratory ...

Background: The objective of this study is to evaluate by means of a systematic review, the efficacy of thymectomy as compared to medical treatment for non-thymomatous myasthenia gravis (MG). Methods: Medline, Embase, and ...

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: To provide an estimated prevalence and describe the clinical features of myasthenia gravis (MG) in Chile. Method: We carried out (i) a prevalence ...

Abstract: Myasthenia gravis is a rare and invalidating disease affecting the neuromuscular junction of voluntary muscles. The classical form of this autoimmune disease is characterized by the presence of antibodies against ...

Myasthenia gravis (MG) is an autoimmune disease characterized by fluctuating muscle weakness, caused by impaired neuromuscular transmission. Patients with MG can present other autoimmune diseases in association, commonly ...

Myasthenia gravis is a rare and invalidating disease affecting the neuromuscular junction of voluntary muscles. The classical form of this autoimmune disease is characterized by the presence of antibodies against the most ...

La Miastenia Gravis (MG) es una enfermedad autoinmune que se produce por el bloqueo postsináptico de la placa mioneural, a través de autoanticuerpos que se unen a los Receptores de Acetilcolina (RACh) o a moléculas de la ...